India Percutaneous Coronary Intervention Market Research Report By Product Type (Coronary Stents, Ballon Catheters, Coronary Guidewires, Guiding Catheters, Guiding Sheaths, Diagnostic Catheters, Crossing Catheters, Inflation Device, Guidance System, Peripheral Thrombectomy System, Embolic Protection System, Accessories), By Vascular Access (Radial, Femoral) and By End User (Hospitals Clinics, Ambulatory Surgical Centers, Others)- Forecast to 2035

India Percutaneous Coronary Intervention Market Overview

As per MRFR analysis, the India Percutaneous Coronary Intervention Market Size was estimated at 664.59 (USD Million) in 2023.The India Percutaneous Coronary Intervention Market is expected to grow from 731.25(USD Million) in 2024 to 2,906.5 (USD Million) by 2035. The India Percutaneous Coronary Intervention Market CAGR (growth rate) is expected to be around 13.366% during the forecast period (2025 - 2035)

Key India Percutaneous Coronary Intervention Market Trends Highlighted

The market for percutaneous coronary intervention in India is expanding significantly due to a number of important considerations. The rising incidence of cardiovascular illnesses in India, which is fueled by dietary changes, stress levels, and lifestyle modifications, is one important factor.The market is growing as a result of government programs that support heart health and provide access to healthcare. The need for percutaneous coronary procedures is increased by the apparent emphasis on preventive healthcare, which promotes early detection and treatment of cardiac disorders.

Furthermore, new developments in angioplasty and stenting-related medical devices are opening up new avenues for investigation in this sector. While the advent of less invasive procedures is speeding up recovery and lowering hospital stays, advancements in drug-eluting and bioresorbable stents are boosting patient outcomes.

By expanding healthcare infrastructure initiatives, these advances not only serve the expanding urban population but also reach rural areas. Recent trends indicate that more healthcare facilities are implementing cutting-edge cardiac care technologies.As specialized care providers become more important players in the market, hospitals are concentrating on enhancing their cardiac care units. Higher success rates are also being attributed to improved PCI procedure training for medical practitioners.

Furthermore, the widespread use of government-sponsored health insurance programs has reduced the cost of these therapies, increasing patient acceptance. All of these factors lead to a strong shift in India toward more affordable and effective cardiac care options, which bodes well for the market for percutaneous coronary intervention.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

India Percutaneous Coronary Intervention Market Drivers

Rising Incidence of Cardiovascular Diseases

The rise in cardiovascular diseases in India is a significant driver for the India Percutaneous Coronary Intervention Market. According to a report by the Indian Heart Association, approximately 1.5 million deaths occur annually due to heart diseases, which accounts for around 26% of all deaths in the country.Factors such as increasing sedentary lifestyles, dietary changes, and growing obesity rates contribute to the growing prevalence of coronary artery diseases. With these alarming statistics, healthcare providers and organizations like the All India Institute of Medical Sciences (AIIMS) are focusing on enhancing interventional cardiology services.

Investments in advanced technologies and training for healthcare professionals are vital to meet the rising demand for percutaneous coronary interventions, leading to a substantial growth trajectory in this market.

Technological Advancements in PCI

The continuous advancements in percutaneous coronary intervention (PCI) technology play a pivotal role in propelling the India Percutaneous Coronary Intervention Market.Devices such as drug-eluting stents (DES) and bioresorbable scaffolds have revolutionized PCI procedures, leading to improved patient outcomes and shorter recovery times. The emergence of minimally invasive techniques has encouraged more patients to opt for these interventions, thus increasing procedure volumes.

Organizations like the Indian Society of Interventional Cardiology are actively promoting training and research into these technologies, which is expected to fuel market growth significantly in the coming years as more hospitals adopt these innovative solutions.

Government Initiatives Improving Healthcare Access

Government initiatives such as the Ayushman Bharat scheme have significantly improved access to healthcare services in India, driving growth in the India Percutaneous Coronary Intervention Market. Launched in 2023, this program aims to provide health coverage for over 500 million citizens, ensuring they have access to essential medical services, including cardiac interventions.

As of 2021, data indicates that the scheme has successfully provided benefits to over 10 million families, specifically catering to low-income households. With increased funding and support from the government, hospitals are better equipped to offer PCI services, thus fostering market growth in this sector.

India Percutaneous Coronary Intervention Market Segment Insights

Percutaneous Coronary Intervention Market Product Type Insights

The India Percutaneous Coronary Intervention Market has shown promising growth, primarily driven by the increasing prevalence of cardiovascular diseases among the population and an aging demographic. The market segmentation in terms of Product Type includes various crucial components fundamental to the success of these procedures.Among these, Coronary Stents play a key role as they are essential devices used to keep arteries open and facilitate blood flow. The importance of Balloon Catheters lies in their ability to aid in the dilation of narrowed blood vessels, effectively enhancing procedural efficiency.

Coronary Guidewires are vital as they assist in navigating through vascular pathways, making them indispensable for successful interventions. Additionally, Guiding Catheters are paramount as they provide the necessary access to coronary arteries, while Guiding Sheaths further support the introduction of other instruments into the vascular system.Diagnostic Catheters enable the assessment of coronary vessel integrity and functionality, contributing to precise diagnostics before intervention. Crossing Catheters are designed to navigate blockages more efficiently, ensuring that treatments can be effectively applied.

The Inflation Device's significance cannot be understated as it is used to inflate balloon catheters effectively, which is critical for achieving optimal vessel dilation. Moreover, Guidance Systems integrates advanced technologies to improve accuracy during procedures, allowing for enhanced patient outcomes and reduced complications.Peripheral Thrombectomy Systems and Embolic Protection Systems are emerging as critical tools in safeguarding against complications like thrombosis during intervention. Accessories play a supporting role, ensuring that all necessary components are available for successful procedures.

Overall, this segmentation underscores the complexity and critical nature of each Product Type within the India Percutaneous Coronary Intervention Market, highlighting the diverse technological advancements aimed at improving health outcomes.Each product type contributes uniquely to the overall effectiveness and safety of percutaneous coronary interventions, showcasing the industry's commitment to addressing the growing burden of cardiovascular diseases in India.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Percutaneous Coronary Intervention Market Vascular Access Insights

The Vascular Access segment within the India Percutaneous Coronary Intervention Market plays a critical role in ensuring effective and safe procedures by providing the pathway for coronary interventions.In recent years, the demand for vascular access techniques, particularly Radial and Femoral access, has been on the rise due to their importance in enhancing patient outcomes and minimizing complications. The Radial approach is gaining traction as it is associated with reduced bleeding risks and shorter hospital stays, making it a preferred option among healthcare providers.

Conversely, the Femoral access method, while traditional, remains significant for more complex interventions and cases where extensive vascular access is required. As India's healthcare landscape evolves, advancements in technology and increased awareness about minimally invasive procedures are expected to contribute to growth in the Vascular Access segment.

Additionally, the rising prevalence of cardiovascular diseases in India serves as a substantial driver for demand in this area. According to Indian health statistics, with the growing focus on improving healthcare infrastructure and access to treatments, both Radial and Femoral access methods will continue to hold significance as the country navigates through its cardiovascular care challenges.

Percutaneous Coronary Intervention Market End User Insights

The End User segment of the India Percutaneous Coronary Intervention Market plays a pivotal role in the overall dynamics of the industry, encompassing various healthcare providers such as Hospitals Clinics, Ambulatory Surgical Centers, and Others.Hospitals Clinics are essential for delivering comprehensive cardiac care, often equipped with advanced technology and skilled professionals to perform complex procedures, thus dominating the market.Ambulatory Surgical Centers are gaining traction due to the rising preference for minimally invasive procedures, providing a more efficient and cost-effective alternative for patients while ensuring quality healthcare services.

The Others category, which may include specialized cardiac rehabilitation centers, also contributes to the overall ecosystem by focusing on holistic patient care and recovery. The increasing prevalence of cardiovascular diseases in India has fueled the demand for these End User facilities, driven by a growing aging population and lifestyle changes.Market growth is further supported by advancements in medical technology and a surge in health awareness, emphasizing the critical role of these segments in enhancing patient outcomes and improving access to cardiac interventions across the nation.

Furthermore, government initiatives supporting healthcare infrastructure are expected to bolster the capabilities of these End Users, resulting in a more robust and responsive healthcare system.

India Percutaneous Coronary Intervention Market Key Players and Competitive Insights

The India Percutaneous Coronary Intervention Market is characterized by a rapidly evolving landscape as the healthcare sector increasingly emphasizes advanced cardiac procedures. Given the rising prevalence of coronary artery diseases in India, numerous companies are entering this market or expanding their existing footprint.Competitive insights reveal that factors such as innovation in products, strategic partnerships, and a focus on enhancing patient outcomes are playing pivotal roles in shaping competitive dynamics. Companies are harnessing new technologies and data analytics to create more effective solutions, thereby intensifying the competition and driving market growth.

The presence of local and international players adds a layer of complexity to the market, with each entity striving to establish a unique identity and capture a significant market share. Terumo Corporation has positioned itself as a formidable player in the India Percutaneous Coronary Intervention Market by offering a diverse range of high-quality cardiovascular products.The company's strengths lie in its commitment to innovation, continuous research and development, and its efficient distribution network across India. By focusing on state-of-the-art technologies and maintaining a customer-centric approach, Terumo Corporation has been able to meet the specific needs of healthcare providers, enhancing their operational efficiency.

Furthermore, Terumo’s comprehensive training and support for healthcare professionals ensure that it maintains a strong presence in the competitive landscape while fostering long-term relationships with key stakeholders in the Indian healthcare system.

Johnson and Johnson has made significant inroads into the India Percutaneous Coronary Intervention Market through its robust portfolio of medical devices and surgical products tailored for cardiac interventions. Its key offerings include advanced stents and catheter systems designed to improve patient outcomes.Johnson and Johnson leverages its vast experience and extensive distribution network to enhance its market presence in India, ensuring that its products are readily available for healthcare institutions. Strengths like high brand recognition, strong relationships with healthcare providers, and ongoing investment in innovation contribute to its competitive advantage.

Furthermore, the company has been expanding its influence in the region through strategic mergers and acquisitions, allowing it not only to enhance its product offerings but also to access new markets and technologies, thereby consolidating its position in the Indian cardiovascular landscape.

Key Companies in the India Percutaneous Coronary Intervention Market Include

• Terumo Corporation


• Johnson and Johnson


• Device Technologies


• Philips Healthcare


• B.Braun Melsungen AG


• Boston Scientific


• Stryker Corporation


• Integer Holdings Corporation


• Zimmer Biomet


• Fujifilm Irvine Scientific


• Abbott Laboratories


• Medtronic


• Becton Dickinson


• Cardinal Health


• Cook Medical

India Percutaneous Coronary Intervention Market Developments

Recent developments in the India Percutaneous Coronary Intervention (PCI) market highlight significant advancements and market dynamics. Terumo Corporation has launched innovative PCI devices aimed at enhancing procedural efficiency and patient outcomes, responding to India's rising cardiovascular disease prevalence.Notably, in October 2023, Johnson Johnson announced a strategic initiative to expand its cardiac care portfolio through collaborations with local hospitals, improving patient access to cutting-edge PCI technologies.

Meanwhile, Boston Scientific and Abbott Laboratories are significantly investing in research and development, contributing to the dynamic nature of the PCI landscape in India. The market has seen a valuation increase driven by these developments, particularly as hospital infrastructure and healthcare expenditure in India have improved.Furthermore, B.Braun Melsungen AG established a partnership with local medical institutions to enhance training and adoption of PCI technologies. Market growth is also fueled by rising disposable income and increased health awareness among the populace.

In a noteworthy event in June 2022, Cook Medical expanded its local manufacturing capabilities in India, signifying confidence in the nation's PCI market potential and serving the growing demand for cardiac interventions.

India Percutaneous Coronary Intervention Market Segmentation Insights

• Percutaneous Coronary Intervention Market Product Type Outlook
  
  
  
  • Coronary Stents
  
  
  • Ballon Catheters
  
  
  • Coronary Guidewires
  
  
  • Guiding Catheters
  
  
  • Guiding Sheaths
  
  
  • Diagnostic Catheters
  
  
  • Crossing Catheters
  
  
  • Inflation Device
  
  
  • Guidance System
  
  
  • Peripheral Thrombectomy System
  
  
  • Embolic Protection System
  
  
  • Accessories
  
  
  
  


• Percutaneous Coronary Intervention Market Vascular Access Outlook
  
  
  
  • Radial
  
  
  • Femoral
  
  
  
  


• Percutaneous Coronary Intervention Market End User Outlook
  
  
  
  • HospitalsClinics
  
  
  • Ambulatory Surgical Centers
  
  
  • Others
  
  
  
  

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	664.59(USD Million)
MARKET SIZE 2024	731.25(USD Million)
MARKET SIZE 2035	2906.5(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	13.366% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Terumo Corporation, Johnson and Johnson, Device Technologies, Philips Healthcare, B.Braun Melsungen AG, Boston Scientific, Stryker Corporation, Integer Holdings Corporation, Zimmer Biomet, Fujifilm Irvine Scientific, Abbott Laboratories, Medtronic, Becton Dickinson, Cardinal Health, Cook Medical
SEGMENTS COVERED	Product Type, Vascular Access, End User
KEY MARKET OPPORTUNITIES	Increasing prevalence of cardiovascular diseases, Technological advancements in PCI devices, Growing aging population demand, Rising healthcare expenditure, Expanding healthcare infrastructure and access
KEY MARKET DYNAMICS	aging population, increasing prevalence of CAD, technological advancements, rise in health awareness, favorable reimbursement policies
COUNTRIES COVERED	India